GSK’s Tres Cantos Medicines Development Campus
GSK partners with Brazil’s Fiocruz on tropical disease research
November 15, 2010Research and Development Chagas disease, Fiocruz, GSK, GSK’s Tres Cantos Medicines Development Campus, GlaxoSmithKline, Oswald Cruz Foundation, leishmaniasis
GlaxoSmithKline and the Brazil-based Oswald Cruz Foundation (Fiocruz) are to research and develop new medicines for tropical diseases Chagas and …
Latest content
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
